Ordenar

Buscar

11/11/2025 Bacteraemia due to E.coli in urinary tract infections in adults: a prospective epidemiological study following implementation of guidelines in a regional hospital
Blancas-Altabella, D, Simonetti, AF, Chico, C, Serdà, S, Jou, E, Moreno-Rubio, E, Pérez-Lopez, C, Carmezim, J, García-Pont, J. Bacteraemia due to E.coli in urinary tract infections in adults: a prospective epidemiological study following implementation of guidelines in a regional hospital. BMC INFECTIOUS DISEASES. 2025; 25(1)DOI:10.1186/s12879-025-11987-z. PMID:41219722. IF:3.000(Q2/4D).
10/11/2025 The Role of Sex, Quality of Life, Self-Esteem and Cognitive Insight in Reducing Personal Stigma in Psychosis
Lamarca, M, Romero-Castillejo, A, Balsells-Mejia, S, Lopez-Carrilero, R, Vila-Badia, R, Pousa, E, Grasa, E, Barrigon, M, Birulés, I, Peláez, T, Gutiérrez-Zotes, A, Cabezas, A, Lorente-Rovira, E, Cid, J, Ruiz-Delgado, I, González-Higueras, F, Legido, T, Moreno-Küstner, B, Barajas, A, Ochoa, S. The Role of Sex, Quality of Life, Self-Esteem and Cognitive Insight in Reducing Personal Stigma in Psychosis. CLINICAL PSYCHOLOGY & PSYCHOTHERAPY. 2025; 32(6)DOI:10.1002/cpp.70171. PMID:41215569. IF:2.700(Q2/3D).
10/11/2025 An Updated Review of Topical Tretinoin in Dermatology: From Acne and Photoaging to Skin Cancer
Balado-Simo, P, Morgado-Carrasco, D, Gomez-Armayones, S, Lopez-Ferrer, A, Barco, D, Ferrándiz-Pulido, C, Podlipnik, S. An Updated Review of Topical Tretinoin in Dermatology: From Acne and Photoaging to Skin Cancer. Journal of Clinical Medicine. 2025; 14(22)DOI:10.3390/jcm14227958. PMID:41302994. IF:2.900(Q1/2D).
10/11/2025 Plasma p-tau217 as a biomarker of Alzheimer's disease pathology in individuals with Down syndrome
Huber, H, Arranz, J, Arslan, B, Leuzy, A, Kittel, O, Di Molfetta, G, Benejam, B, Videla, L, Barroeta, I, Soriano, LD, Maure-Blesa, L, Rodríguez-Baz, I, Infante, JEA, Illán-Gala, I, Bejanin, A, Montoliu-Gaya, L, Lleo, A, Carmona-Iragui, M, Alcolea, D, Blennow, K, Zetterberg, H, Fortea, J, Ashton, NJ. Plasma p-tau217 as a biomarker of Alzheimer's disease pathology in individuals with Down syndrome. Nature Communications. 2025; 16(1)DOI:10.1038/s41467-025-65882-x. PMID:41213934. IF:15.700(Q1/1D).
10/11/2025 Health Status and Use of Healthcare Services of Undocumented Migrant Sex Workers in Catalonia: A Descriptive Study Using Administrative Registries.
Dalmau-Bueno, Albert, Albert-Ballestar, Sergi, Mansilla, Rosa, Garcia-Altes, Anna. Health Status and Use of Healthcare Services of Undocumented Migrant Sex Workers in Catalonia: A Descriptive Study Using Administrative Registries.. International Journal of Environmental Research and Public Health. 2025; 22(11)DOI:10.3390/ijerph22111696. PMID:. IF:(Q/D).
10/11/2025 Estimating the prevalence of chronic insomnia in patients with non-cancer chronic pain: Study protocol of a multicenter cross-sectional study
Moreno, Vicente, Martin-Pardo, Carme, Medel, Javier, Monerris, Mar, Ferrándiz, Marta, Lorente, Luís, Server, Anna, Serrano, Ancor, Carnaval, Thiago, Montes, Antonio, Videla, Sebastián. Estimating the prevalence of chronic insomnia in patients with non-cancer chronic pain: Study protocol of a multicenter cross-sectional study. Medicine: Case Reports And Study Protocols. 2025; 6(6)DOI:10.1097/MD9.0000000000000386. PMID:. IF:(Q/D).
09/11/2025 Study protocol for developing the evaluation instrument of guideline adherence to GRADE approach (GRADE-Check)
Jin, YH, Yan, SY, Yao, XM, Dahm, P, Alonso-Coello, P, Brignardello-Petersen, R, Keitz, S, Rylance, J, Cheung, M, Agoritsas, T, Kunkle, R, Murad, MH, Guyatt, G. Study protocol for developing the evaluation instrument of guideline adherence to GRADE approach (GRADE-Check). BMJ Open. 2025; 15(11)DOI:10.1136/bmjopen-2025-105534. PMID:41213689. IF:2.300(Q2/3D).
08/11/2025 Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial
De Santis, M, Redorta, JP, Nishiyama, H, Krawczynski, M, Seyitkuliev, A, Novikov, A, Guerrero-Ramos, F, Zukov, R, Kato, M, Kawahara, T, Goeman, L, Puente, J, Hellmis, E, Powles, T, Radziszewski, P, Gust, KM, Vasey, P, Bigot, P, Fradet, Y, Hunting, J, Armstrong, J, Boulos, S, Hois, S, Shore, ND. Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial. LANCET. 2025; 406(10516)DOI:10.1016/S0140-6736(25)01897-5. PMID:41115436. IF:88.500(Q1/1D).